Zymeworks Inc (ZYME)
13.68
-0.87
(-5.98%)
USD |
NASDAQ |
Nov 21, 16:00
13.60
-0.08
(-0.58%)
After-Hours: 20:00
Zymeworks Profit Margin (Quarterly): -186.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -186.6% |
| June 30, 2024 | -195.8% |
| March 31, 2024 | -315.6% |
| December 31, 2023 | -85.56% |
| September 30, 2023 | -173.8% |
| June 30, 2023 | -730.5% |
| March 31, 2023 | -68.45% |
| December 31, 2022 | 76.88% |
| September 30, 2022 | -1.82K% |
| June 30, 2022 | -1.19K% |
| March 31, 2022 | -3.79K% |
| December 31, 2021 | -197.0% |
| September 30, 2021 | -1.38K% |
| June 30, 2021 | -3.81K% |
| March 31, 2021 | -6.92K% |
| December 31, 2020 | -241.7% |
| September 30, 2020 | -2.75K% |
| June 30, 2020 | -315.2% |
| Date | Value |
|---|---|
| March 31, 2020 | -376.5% |
| December 31, 2019 | -3.85K% |
| September 30, 2019 | -387.7% |
| June 30, 2019 | -368.9% |
| March 31, 2019 | -114.4% |
| December 31, 2018 | 32.06% |
| September 30, 2018 | -912.9% |
| June 30, 2018 | -26.70% |
| March 31, 2018 | -53.01K% |
| December 31, 2017 | 65.37% |
| September 30, 2017 | -13.65K% |
| June 30, 2017 | -817.3% |
| March 31, 2017 | -6.92K% |
| December 31, 2016 | -505.2% |
| September 30, 2016 | -570.8% |
| June 30, 2016 | -117.0% |
| March 31, 2016 | -1.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.92K%
Minimum
Mar 2021
76.88%
Maximum
Dec 2022
-1.42K%
Average
-346.1%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.06% |
| Return on Assets | -21.10% |
| Return on Invested Capital | -27.06% |
| Operating Margin (Quarterly) | -214.1% |
| Return on Net Operating Assets | -112.0% |